Radiofrequency Catheter Ablation for Arrhythmic Storm in Patients with An Implantable Cardioverter Defibrillator
Autor: | Lluís Mont, Ulises Rojel, Mariona Matas, Rose Mary Ferreira Lisboa da Silva, Josep Brugada, Santiago Nava |
---|---|
Rok vydání: | 2004 |
Předmět: |
Adult
Male Tachycardia medicine.medical_specialty Adolescent Radiofrequency ablation medicine.medical_treatment Bundle-Branch Block Catheter ablation Implantable defibrillator Ventricular tachycardia law.invention Electrocardiography law Internal medicine medicine Humans Aged medicine.diagnostic_test business.industry General Medicine Middle Aged Implantable cardioverter-defibrillator Ablation medicine.disease Defibrillators Implantable Catheter Ablation Tachycardia Ventricular Cardiology Female medicine.symptom Cardiology and Cardiovascular Medicine business |
Zdroj: | Pacing and Clinical Electrophysiology. 27:971-975 |
ISSN: | 1540-8159 0147-8389 |
DOI: | 10.1111/j.1540-8159.2004.00567.x |
Popis: | The aim of the study was to analyze the usefulness of RFA in controlling arrhythmic storm due to hemodynamically stable VT in a cohort of patients with an ICD and to evaluate the incidence of arrhythmic storm among patients with an ICD. A group of 13 (3%) of 403 consecutive ICD recipients were submitted to RFA of VT during an arrhythmic storm. Two additional patients were referred from other institutions. Standard criteria were used for VT endocardial ablation. A transcatheter epicardial approach was required in three patients. A total of 18 procedures were performed in 15 patients. A mean of 13.2 +/- 9.7 pulses of RF were delivered. Clinical tachycardia was successfully ablated in 12 (80%) patients. One patient died in incessant VT, 1 patient underwent heart transplant, and 1 was treated with direct current ablation. During a mean follow-up of 12 +/- 17 months, only two patients suffered a single episode of VT. Arrhythmic storm requiring VT ablation was uncommon among patients with an ICD and occurred late after ICD implantation. The arrhythmic episode was successfully controlled in the majority of patients with endocardial or epicardial RFA. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |